[Featured Stock] J.Cys Medical Rises 18% on Tender Offer News
JCS Medical's stock price is rising more than 18% following the news of a tender offer.
As of 2:01 PM on the 10th, JCS Medical is trading at 12,770 KRW, up 18.68% (2,010 KRW) from the previous trading day.
The decision by Archimede Group, a French healthcare-focused private equity fund (PEF) manager, to make a tender offer for JCS Medical common shares acted as a positive catalyst. Archimede, established in 2014, is a French PEF manager that primarily invests in healthcare sectors such as biopharmaceuticals, medical technology, and in vitro diagnostics.
JCS Medical announced that its largest shareholder will be changed to Syracuse Subco on this day.
Hot Picks Today
Per-Capita Burden to Surge to 6.73 Million Won ... "Even Full Salary Isn't Enough for Interest Payments," Lament Overleveraged Borrowers
- Missing Out on a 60 Trillion Won Deal and Suffering a 20% Stock Plunge, But..."Buy While It's Cheap, Hanwha Ocean Has a Rebound Opportunity" [Click e-Stock]
- "Will I Really Be Left Out If I Don't Use It?"... The App Used by 23 Million Koreans Monthly, Is Naver Feeling the Pressure?
- 30 Beluga Whales Dramatically Rescued After Two Years Trapped in Shuttered Theme Park
- ‘Paradise Island’ Turns into ‘Hell’...4,000 U.S. Soldiers Endure Heat With Only Fans
Syracuse Subco is a corporation newly established in Korea by Archimede in April, and it announced that from today until the 22nd of next month, it will make a tender offer to purchase 55,724,838 common shares of JCS Medical at 13,000 KRW per share. This corresponds to 72.0% of the total potential issued shares of JCS Medical.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
![[Briefing] National Growth Fund to Expand to 200 Trillion Won... New 'Ultra-Long-Term Technology Investment Fund' with 10-Year Patient Capital Introduced](https://cwcontent.asiae.co.kr/asiaresize/307/2026071511225546911_1784082175.jpg)